Search for: "C-Innovation, LLC" Results 41 - 60 of 530
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2015, 5:47 am by Lawrence B. Ebert
In a post on 20 Feb 2015 titled --Study finds patent licensing rarely results in innovation --, Inman discusses theFeldman/Lemley paper -- “Does Patent Licensing Mean Innovation? [read post]
9 Mar 2015, 12:23 pm
| Dutch Minister and EPO immunity | CJEU and droit de suite in Case C-41/14 Christie's France | Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others | Pangyrus Ltd v OHIM, RSVP Design Ltd | China and smartphone patents | UK against groundless threats to sue for IP infringement | Polar bears | Patent needs strictness, complexity and fuzziness. [read post]
9 Feb 2015, 1:15 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters  | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
27 Jul 2011, 9:36 am by Tomassi Law Associates
T: 212-255-8386 E: itay@sommerfield.com (C) Copyright 2010 GlobeNewswire, Inc. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
Without being able to patent those findings, companies could be discouraged from engaging in such research, ultimately stifling innovation. [read post]
23 Feb 2015, 2:55 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
2 Mar 2015, 2:43 pm
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems& Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
5 Feb 2018, 9:16 am by Rebecca Tushnet
Pride Solutions, LLC, 2018 WL 688324, No. 13 C 3418 (N.D. [read post]
4 Feb 2016, 7:58 am by Mark Astarita
Tallman, President and CEO, the Georgia Hispanic Chamber of Commerce, AtlantaAnnemarie Tierney, Vice President and Head of Strategy and New Markets, NASDAQ Private Market, New YorkGregory C. [read post]
14 Apr 2010, 11:27 am by Stuart Blake
The SEC guidance provides that these climate change disclosures may be required under the Description of Business (Item 101), Legal Proceedings (103), Management’s Discussion and Analysis (303), and Risk Factors (503(c)) sections of companies’ filings under Regulation S-K. [read post]
17 Aug 2018, 5:58 am by James Yang
Orange County is a hotbed of innovation, especially considering its size. [read post]
17 Apr 2014, 7:10 pm by Nikki Siesel
In In re Innovation Ventures, LLC  the Examining Attorney first refused the trademark application on the basis of merely descriptiveness and failure to function as a trademark. [read post]
16 Jul 2012, 8:22 am by Russell S. Whittle Esq. MSCC
GlaxoSmithKline, LLC, concluding that any private party may bring an action under §1395y(b)(3)(A), as it establishes a private cause of action for damages. [read post]